3 February 2020, Moscow – The Association of International Pharmaceutical Manufacturers (AIPM) announces that according to the Statutes and by the decision of the AIPM Board of Directors Mrs. Oxana Monge, General Manager, Sanofi Eurasia, has been elected the Chair of the Board of Directors at AIPM.
Mrs. Oxana Monge has been working in pharmaceutical industry for over 19 years in different managerial positions, including marketing, strategic planning, and business management at multinational pharmaceutical companies both in Russia and on the international level. Since October 2018 Mrs. Monge has been appointed the General Manager at Sanofi Eurasia. In November of the same year she became a member of the Board of Directors at AIPM.
According to the Statutes, the Chair of the Board of Directors of AIPM is elected once in two years with a possibility for a one re-election.
"The contribution of the Association of International Pharmaceutical Manufacturers to the development of modern, socially responsible, advanced and patient-oriented pharmaceutical industry in Russia is hard to overestimate. Over the past 25 years, the Association has done much to help the Russian industry to approach the advanced global standards. Of course, there is still a lot of work ahead. I am grateful for your confidence and I accept this new position enthusiastically, being certain that our joint efforts are for the better of the pharmaceutical industry and for the better of Russian patients," - said Mrs. Monge, General Manager at Sanofi Eurasia, Chair of the Board of Directors of AIPM.
The Association promotes the development of a sustainable and predictable pharmaceutical market in Russia. It strives to improve the accessibility of efficient and modern medicines and healthcare technologies while advocating the basic principles of strong protection of rights on intellectual property and compliance with high ethical standards. At the same time, AIPM member companies have made a significant contribution to the development of Russian pharmaceutic industry, enhancing its professional, scientific & technical competencies, various kinds of drug manufacturing localization, transfer of state-of-the-art technology, creating highly-qualified jobs, and more.
"In a situation of increased expectations from the healthcare system that should propose decisions for social and economic development of the country, the industry, including the Association of International Pharmaceutical Manufacturers, will have to make extra efforts to prove the reliability of their partnership with the government, the professional medical and patient communities, especially when it comes to introducing innovations, making the most advanced, efficient and safe drugs more accessible to prevent and treat socially significant diseases. We welcome Mrs. Oxana Monge as the newly elected Chair of our Board of Directors and we are sure that she will adhere to our professional priorities and reinforce the consolidation of the industry in the key areas," - said Vladimir Shipkov, Executive Director of AIPM.
The Association of International Pharmaceutical Manufacturers (AIPM) was established in 1994 and represents in the Russian Federation the leading international pharmaceutical companies - producers and developers of modern effective, safe and high-quality medicines. Today, AIPM unites more than 60 international companies that provide over 80% of the world’s pharmaceutical products and over 60% of medicines imported to the Russian Federation.
For additional information, please contact:
Elena Yankovskaya, Communications Lead, AIPM
+7 (495) 933 70 40, E.Yankovskaya@aipm.org